Cat. No. 5106
Chemical Name: 3-([1,4'-Bipiperidin]-1'-ylmethyl)-7-
Biological ActivityPotent and selective TRPV4 antagonist (IC50 values are 2 and 40 nM for rat and human receptors, respectively); inhibits Ca2+ influx through TRPV4 channels. Prevents and reverses pulmonary edema after myocardial infarction in vivo models. Selective over a panel of ~200 human receptors, channels and enzymes. Orally active.
Licensing InformationSold for research purposes under agreement from GlaxoSmithKline
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Certificate of Analysis / Product Datasheet / Safety Datasheet
References are publications that support the products' biological activity.
Cheung et al (2017) Discovery of GSK2193874: an orally active, potent, and selective blocker of transient receptor potential vanilloid 4. ACS Med.Chem.Lett. 8 549. PMID: 28523109.
Thorneloe et al (2012) An orally active TRPV4 channel blocker prevents and resolves pulmonary edema induced by heart failure. Sci.Transl.Med. 4 159. PMID: 23136043.
If you know of a relevant reference for GSK 2193874 please let us know.
Citations are publications that use Tocris products.
Do you know of a great paper that uses GSK 2193874 from Tocris? If so please let us know.
View Related Products by Product Action
Keywords: GSK 2193874, supplier, GSK2193874, potent, selectiveTRPV4, inhibitors, antagonists, orally, active, transient, receptors, potential, vanilloids, channels, myocardial, infarction, pulmonary, oedema, edema, inhibits, Tocris Bioscience, TRPV Antagonist products
Find multiple products by catalog number
August 20 - 24, 2017
Paris , France